← Back to Search

Aerobic Exercise for Type 2 Diabetes (EPC-DM Trial)

N/A
Waitlist Available
Research Sponsored by Baltimore VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
If woman, postmenopausal >1 year
Age 50-80
Must not have
Poorly controlled hypertension or dyslipidemia
History of cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is designed to study how well exercise training works to improve cardiovascular function in people with type 2 diabetes, as well as the mechanisms underlying Endothelial Progenitor Cell (EPC) dysfunction in this population.

Who is the study for?
This trial is for non-smoking adults aged 50-80 with type 2 diabetes, particularly those who are sedentary. Women must be postmenopausal for over a year. It's not suitable for individuals with kidney or liver diseases, uncontrolled high blood pressure or cholesterol levels, or a history of cancer, heart disease, or stroke.
What is being tested?
The study is testing whether aerobic exercise training can improve the function and number of endothelial progenitor cells (EPCs) in older adults with type 2 diabetes. The goal is to see if this leads to better blood vessel health and glucose metabolism.
What are the potential side effects?
Aerobic exercise is generally safe but may include muscle soreness, fatigue, and an increased risk of injury. Specific side effects will depend on individual health status and exercise intensity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman who has been postmenopausal for more than a year.
Select...
I am between 50 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My blood pressure or cholesterol levels are not well-managed.
Select...
I have had cancer in the past.
Select...
I have a history of heart disease or stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: T2DMExperimental Treatment1 Intervention
Type 2 Diabetes Mellitus
Group II: IGTExperimental Treatment1 Intervention
Impaired Glucose Tolerance
Group III: NGTActive Control1 Intervention
Normal Glucose Tolerance

Find a Location

Who is running the clinical trial?

Baltimore VA Medical CenterLead Sponsor
32 Previous Clinical Trials
3,025 Total Patients Enrolled
University of Maryland, BaltimoreOTHER
713 Previous Clinical Trials
379,300 Total Patients Enrolled
4 Trials studying Diabetes
23,990 Patients Enrolled for Diabetes

Media Library

Aerobic Exercise Training Clinical Trial Eligibility Overview. Trial Name: NCT01176578 — N/A
Diabetes Research Study Groups: T2DM, NGT, IGT
Diabetes Clinical Trial 2023: Aerobic Exercise Training Highlights & Side Effects. Trial Name: NCT01176578 — N/A
Aerobic Exercise Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT01176578 — N/A
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top